Andy Jennings

3.0k total citations
18 papers, 1.5k citations indexed

About

Andy Jennings is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Andy Jennings has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Computational Theory and Mathematics. Recurrent topics in Andy Jennings's work include Computational Drug Discovery Methods (5 papers), Peptidase Inhibition and Analysis (5 papers) and Biochemical and Molecular Research (4 papers). Andy Jennings is often cited by papers focused on Computational Drug Discovery Methods (5 papers), Peptidase Inhibition and Analysis (5 papers) and Biochemical and Molecular Research (4 papers). Andy Jennings collaborates with scholars based in United States and Japan. Andy Jennings's co-authors include Kathleen Aertgeerts, R.J. Skene, G. Snell, Mike Tennant, Jason K. Yano, Yiqin Wu, Marc Navre, Lihong Shi, Charles E. Grimshaw and Ron de Jong and has published in prestigious journals such as Nature, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Andy Jennings

18 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andy Jennings United States 14 895 541 305 293 287 18 1.5k
Toshimasa Tanaka Japan 27 1.3k 1.4× 450 0.8× 992 3.3× 340 1.2× 190 0.7× 59 2.6k
Robert J. Ife United Kingdom 23 865 1.0× 244 0.5× 417 1.4× 138 0.5× 119 0.4× 52 1.7k
Vandana Sridhar United States 16 742 0.8× 462 0.9× 72 0.2× 98 0.3× 115 0.4× 25 1.5k
Markus Boehringer Switzerland 10 588 0.7× 170 0.3× 209 0.7× 147 0.5× 116 0.4× 11 898
Jefferson Tilley United States 20 683 0.8× 160 0.3× 563 1.8× 160 0.5× 98 0.3× 64 1.4k
Jeffrey A. Robl United States 23 1.0k 1.1× 182 0.3× 668 2.2× 230 0.8× 128 0.4× 61 1.9k
Ross Weatherman United States 16 662 0.7× 230 0.4× 338 1.1× 125 0.4× 60 0.2× 25 1.3k
Martin Rowlands United Kingdom 29 1.5k 1.7× 273 0.5× 637 2.1× 266 0.9× 36 0.1× 67 2.6k
G. Pochetti Italy 26 1.2k 1.3× 285 0.5× 408 1.3× 59 0.2× 89 0.3× 73 1.7k
Mario Cardozo United States 18 773 0.9× 171 0.3× 552 1.8× 67 0.2× 76 0.3× 31 1.4k

Countries citing papers authored by Andy Jennings

Since Specialization
Citations

This map shows the geographic impact of Andy Jennings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Jennings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Jennings more than expected).

Fields of papers citing papers by Andy Jennings

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Jennings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Jennings. The network helps show where Andy Jennings may publish in the future.

Co-authorship network of co-authors of Andy Jennings

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Jennings. A scholar is included among the top collaborators of Andy Jennings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Jennings. Andy Jennings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mullarky, Edouard, Jiayi Xu, David J. Huggins, et al.. (2019). Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells. Bioorganic & Medicinal Chemistry Letters. 29(17). 2503–2510. 41 indexed citations
2.
Cheruvallath, Zacharia S., Stephen L. Gwaltney, M. Sabat, et al.. (2017). Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators. Bioorganic & Medicinal Chemistry Letters. 27(12). 2678–2682. 15 indexed citations
3.
Lanier, Marion, Derek C. Cole, Michael G. Klein, et al.. (2017). Repurposing Suzuki Coupling Reagents as a Directed Fragment Library Targeting Serine Hydrolases and Related Enzymes. Journal of Medicinal Chemistry. 60(12). 5209–5215. 13 indexed citations
4.
Grimshaw, Charles E., Andy Jennings, Ruhi Kamran, et al.. (2016). Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism. PLoS ONE. 11(6). e0157509–e0157509. 43 indexed citations
5.
Lanier, Marion, Géza Ambrus, Derek C. Cole, et al.. (2014). A Fragment-Based Approach to IdentifyingS-Adenosyl-l-methionine -Competitive Inhibitors of CatecholO-Methyl Transferase (COMT).. Journal of Medicinal Chemistry. 57(12). 5459–5463. 10 indexed citations
6.
Srivastava, Ankita, Jason K. Yano, Yoshihiko Hirozane, et al.. (2014). High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875. Nature. 513(7516). 124–127. 288 indexed citations
7.
Cheruvallath, Zacharia S., Stephen L. Gwaltney, M. Sabat, et al.. (2013). Design, synthesis and SAR of novel glucokinase activators. Bioorganic & Medicinal Chemistry Letters. 23(7). 2166–2171. 27 indexed citations
8.
Gangloff, Anthony R., Jason W. Brown, Ron de Jong, et al.. (2013). Discovery of novel benzo[b][1,4]oxazin-3(4H)-ones as poly(ADP-ribose)polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(16). 4501–4505. 28 indexed citations
9.
Jennings, Andy. (2011). Chemical Informatics: Using Molecular Shape Descriptors in Structure-Based Drug Design. Methods in molecular biology. 841. 235–250. 1 indexed citations
10.
Aertgeerts, Kathleen, R.J. Skene, Jason K. Yano, et al.. (2011). Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein. Journal of Biological Chemistry. 286(21). 18756–18765. 310 indexed citations
11.
Bressi, Jerome C., Ron de Jong, Yiqin Wu, et al.. (2010). Benzimidazole and imidazole inhibitors of histone deacetylases: Synthesis and biological activity. Bioorganic & Medicinal Chemistry Letters. 20(10). 3138–3141. 47 indexed citations
12.
Bressi, Jerome C., Andy Jennings, R.J. Skene, et al.. (2010). Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides. Bioorganic & Medicinal Chemistry Letters. 20(10). 3142–3145. 213 indexed citations
13.
Zhang, Zhiyuan, Michael B. Wallace, Jun Feng, et al.. (2010). Design and Synthesis of Pyrimidinone and Pyrimidinedione Inhibitors of Dipeptidyl Peptidase IV. Journal of Medicinal Chemistry. 54(2). 510–524. 103 indexed citations
14.
Jennings, Andy & Mike Tennant. (2007). Selection of Molecules Based on Shape and Electrostatic Similarity:  Proof of Concept of “Electroforms”. Journal of Chemical Information and Modeling. 47(5). 1829–1838. 46 indexed citations
15.
Jennings, Andy & Mike Tennant. (2006). Discovery strategies in a pharmaceutical setting: the application of computational techniques. Expert Opinion on Drug Discovery. 1(7). 709–721. 6 indexed citations
16.
Aertgeerts, Kathleen, Irena Levin, Lihong Shi, et al.. (2005). Structural and Kinetic Analysis of the Substrate Specificity of Human Fibroblast Activation Protein α. Journal of Biological Chemistry. 280(20). 19441–19444. 229 indexed citations
17.
Tari, Leslie W., Duncan E. McRee, & Andy Jennings. (2005). Use of high-throughput crystallography and in silico methods for structure-based drug design.. PubMed. 45. 107–29. 2 indexed citations
18.
Hosfield, David J., Yiqin Wu, R.J. Skene, et al.. (2004). Conformational Flexibility in Crystal Structures of Human 11β-Hydroxysteroid Dehydrogenase Type I Provide Insights into Glucocorticoid Interconversion and Enzyme Regulation. Journal of Biological Chemistry. 280(6). 4639–4648. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshimasa Tanaka Breakdown of academic impact, for papers by Robert J. Ife Breakdown of academic impact, for papers by Vandana Sridhar Breakdown of academic impact, for papers by Markus Boehringer Breakdown of academic impact, for papers by Jefferson Tilley Breakdown of academic impact, for papers by Jeffrey A. Robl Breakdown of academic impact, for papers by Ross Weatherman Breakdown of academic impact, for papers by Martin Rowlands Breakdown of academic impact, for papers by G. Pochetti Breakdown of academic impact, for papers by Mario Cardozo
Rankless by CCL
2026